Covalon Technologies (OTCMKTS:CVALF) Announces Earnings Results

Covalon Technologies (OTCMKTS:CVALF) released its earnings results on Friday. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.06, Zacks reports. Covalon Technologies had a return on equity of 12.33% and a net margin of 8.58%.

Covalon Technologies Price Performance

CVALF traded up $0.04 on Friday, reaching $2.25. 33,532 shares of the company traded hands, compared to its average volume of 11,841. The company has a market cap of $61.65 million, a price-to-earnings ratio of 32.15 and a beta of -0.29. The stock’s 50 day moving average price is $2.23 and its 200-day moving average price is $2.32. Covalon Technologies has a 52-week low of $0.74 and a 52-week high of $3.08.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.